Paolo Fusar-Poli mainly focuses on Psychosis, Psychiatry, Schizophrenia, Neuroscience and Meta-analysis. He is involved in the study of Psychosis that focuses on At risk mental state in particular. The concepts of his Psychiatry study are interwoven with issues in Systematic review and Randomized controlled trial.
His Schizophrenia research is multidisciplinary, relying on both Brain activity and meditation, Psychopathology, Disease and Functional neuroimaging. His Neuroscience research focuses on subjects like Cannabidiol, which are linked to Anxiolytic. He combines subjects such as Sample size determination and Receiver operating characteristic with his study of Meta-analysis.
Paolo Fusar-Poli focuses on Psychosis, Psychiatry, Schizophrenia, Neuroscience and Clinical psychology. His study explores the link between Psychosis and topics such as Audiology that cross with problems in Working memory. His research is interdisciplinary, bridging the disciplines of Meta-analysis and Psychiatry.
His research in Schizophrenia intersects with topics in Cohort study, Randomized controlled trial and Pediatrics. His research links Cannabidiol with Neuroscience. Paolo Fusar-Poli works mostly in the field of Clinical psychology, limiting it down to concerns involving Systematic review and, occasionally, Odds ratio.
His main research concerns Psychosis, Psychiatry, Clinical psychology, Meta-analysis and Mental health. His Psychosis study incorporates themes from Schizophrenia, Internal medicine, Cohort study, DSM-5 and Neuroimaging. His research integrates issues of Placebo, Cognition and Autism spectrum disorder in his study of Schizophrenia.
His Psychiatry research focuses on Cumulative incidence and how it connects with Medical diagnosis. His Clinical psychology research is multidisciplinary, relying on both Psychological intervention, Observational study, Systematic review, Disease and PsycINFO. Paolo Fusar-Poli focuses mostly in the field of Meta-analysis, narrowing it down to topics relating to Pregnancy and, in certain cases, Overweight and Relative risk.
His scientific interests lie mostly in Psychosis, Clinical psychology, Psychiatry, Schizophrenia and Mental health. He merges Psychosis with Crisis management in his study. His Clinical psychology research includes elements of PsycINFO, Systematic review, Prospective cohort study and Risk factor.
Paolo Fusar-Poli frequently studies issues relating to Quality of life and Psychiatry. His studies deal with areas such as Meta-analysis, Vitamin D and neurology, Cognition and Clinical significance as well as Schizophrenia. His Mental health research includes themes of Family medicine, Anxiety, Supportive psychotherapy, Public health and Pandemic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Jonathan P Rogers;Edward Chesney;Dominic Oliver;Thomas A Pollak;Thomas A Pollak.
The Lancet Psychiatry (2020)
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies.
Paolo Fusar-Poli;Anna Placentino;Francesco Carletti;Paola Landi.
Journal of Psychiatry & Neuroscience (2009)
Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Paolo Fusar-Poli;Ilaria Bonoldi;Alison R. Yung;Stefan Borgwardt.
Archives of General Psychiatry (2012)
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Paolo Fusar-Poli;Stefan Borgwardt;Andreas Bechdolf;Jean Addington.
JAMA Psychiatry (2013)
Cognitive Functioning in Prodromal Psychosis: A Meta-analysis
Paolo Fusar-Poli;Giacomo Deste;Renata Smieskova;Stefano Barlati.
Archives of General Psychiatry (2012)
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Sagnik Bhattacharyya;Paul D Morrison;Paolo Fusar-Poli;Paolo Fusar-Poli;Rocio Martin-Santos.
Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis
Paolo Fusar-Poli;Barnaby Nelson;Lucia Valmaggia;Alison R. Yung.
Schizophrenia Bulletin (2014)
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Paolo Fusar-Poli;Evangelos Papanastasiou;Daniel Stahl;Matteo Rocchetti.
Schizophrenia Bulletin (2015)
Cannabis and anxiety: a critical review of the evidence
José Alexandre Crippa;Antonio Waldo Zuardi;Rocio Martín-Santos;Sagnik Bhattacharyya.
Human Psychopharmacology-clinical and Experimental (2009)
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
Paolo Fusar-Poli;R Smieskova;Matthew Kempton;B C Ho.
Neuroscience & Biobehavioral Reviews (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: